Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
Graziella Pompei, Cardiologist at Romagna Local Health Authority, PHD Student at University of Ferrara, shared on LinkedIn:
”Is aspirin still a valid alternative to clopidogrel in the context of double antithrombotic therapy (antiplatelet plus OAC) in patients requiring chronic OAC undergoing PCI with DES implantation?
Our post-hoc analysis of the PERSEO registry, available online on Journal of Thrombosis and Thrombolysis and presented at the EuroPCR 2026 Congress, aimed to address this question.”
Title: Clopidogrel vs. aspirin in addition to oral anticoagulation as part of double antithrombotic therapy following PCI: a post-hoc analysis of the PERSEO registry
Authors: Andrea Rubboli, Graziella Pompei, Salvatore De Rosa, Paolo Calabrò, Carolina Moretti, Bernardo Cortese, Mauro Colletta, Vanessa Porretta, Giuseppe Andò, Alessandro Sciahbasi
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026
-
Jul 13, 2026, 17:39Pascal Boulanger: Send a Postcard to Your Lab Staff From ISTH 2026
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026